CompletedPhase 1NCT02274051
The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia
Studying Familial dysautonomia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NYU Langone Health
- Principal Investigator
- Horacio Kaufmann, MDNYU School of Medicine
- Intervention
- Kinetin(dietary_supplement)
- Enrollment
- 15 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2009 – 2019
Study locations (1)
- NYU Langone Medical Center, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02274051 on ClinicalTrials.govOther trials for Familial dysautonomia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06863207Autonomic Reactivity and Personalized NeurostimulationMedical College of Wisconsin
- ENROLLING BY INVITATIONPHASE2NCT06148311Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial DysautonomiaNYU Langone Health
- ACTIVE NOT RECRUITINGPHASE2NCT06128356Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial DysautonomiaNYU Langone Health
- RECRUITINGNCT03920774The Natural History of Familial DysautonomiaNYU Langone Health